Anthem typically follows FDA label criteria: BMI 30 (obesity) or BMI 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea
Common experiences: Mild nausea affecting about 40% of people Injection site reactions (redness, mild itching) Some changes in bowel habits Reduced interest in large meals Weight loss: Typically 3-5% by end of month 1 Management priority: Establish good habits now
The medication is being prescribed for type 2 diabetes, moderate-to-severe obstructive sleep apnea or certain forms of MASH because those uses may need to be processed through your regular Medicare Part D plan
It is rebuilding muscle, replenishing iron stores, and supporting a brain that is forming entirely new neural pathways around caregiving
compounded), cost, and whether genetic or biomarker testing is integrated
Roche indicated that patients seeking maximum weight loss might choose more potent therapies like its experimental dual-acting enicepatide, while others might prefer more modest weight loss with fewer side effects for easier long-term adherence
